Engineers Gate Manager LP

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1620220 NEW YORK, NY

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,974,707

+$162,236 QoQ

Shares Held

36,495

-18.6% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#165

of 497 holders

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names. ARWR ranks #13 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,974,707	36,495	-18.6%	Shares	Sole	2026-08-14
2026-03-31	$2,812,471	44,856	+126.9%	Shares	Sole	2026-05-15
2025-12-31	$1,312,663	19,772	-73.4%	Shares	Sole	2026-02-17
2025-06-30	$1,175,599	74,405	+83.4%	Shares	Sole	2025-08-14
2025-03-31	$516,836	40,568	-42.0%	Shares	Sole	2025-05-15
2024-12-31	$1,314,326	69,911	+21.0%	Shares	Sole	2025-02-14
2024-09-30	$1,118,966	57,768	+184.4%	Shares	Sole	2024-11-14
2023-09-30	$545,783	20,312	-5.3%	Shares	Sole	2023-11-14
2023-06-30	$764,550	21,440	-64.6%	Shares	Sole	2023-08-14
2023-03-31	$1,538,071	60,554	+162.9%	Shares	Sole	2023-05-15
2022-03-31	$1,059,149	23,030	+337.8%	Shares	Sole	2022-05-16
2021-12-31	$348,738	5,260	-40.6%	Shares	Sole	2022-02-14
2021-09-30	$552,380	8,848	+89.5%	Shares	Sole	2021-11-15
2021-06-30	$386,769	4,670	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.